A New Assay for Functional Screening of BRCA2 Linker Region Mutations Identifies Variants That Alter Chemoresistance to Cisplatin

Experimental Cell Research - United States
doi 10.1016/j.yexcr.2011.06.010
Full Text
Abstract

Available in full text

Categories
Cell Biology
Date
Authors
Publisher

Elsevier BV

Related search

Pharmacogenetic Variants in TPMT Alter Cellular Responses to Cisplatin in Inner Ear Cell Lines

PLoS ONE
Multidisciplinary
2017English

A High-Throughput Functional Complementation Assay for Classification of BRCA1 Missense Variants

Cancer Discovery
Oncology
2013English

Mutations That Alter the Transmission of Chloroplast Genes in Chlamydomonas

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1974English

Quantitative Analysis of BRCA1 and BRCA2 Germline Splicing Variants Using a Novel RNA-Massively Parallel Sequencing Assay

Frontiers in Oncology
Cancer ResearchOncology
2018English

Screening for Learning and Memory Mutations: A New Approach

Acta Psychologica Sinica
Psychology
2010English

A Simple P53 Functional Assay for Screening Cell Lines, Blood, and Tumors.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1995English

A Novel High-Throughput Screening Assay for Discovery of Molecules That Increase Cellular Tetrahydrobiopterin

Journal of Biomolecular Screening
Molecular MedicinePharmacologyBiochemistryAnalytical ChemistryBiotechnologyDrug Discovery
2011English

Somatic Mutations in CCK2R Alter Receptor Activity That Promote Oncogenic Phenotypes

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2012English

Functional Screening Identifies miR-315 as a Potent Activator of Wingless Signaling

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy